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Human African trypanosomiasis or sleeping sickness
is a devastating disease that kills all those infected unless
treated. Sleeping sickness tends to affect the poorest and
marginalized rural communities with least access to health
care. The acute form of the disease caused by T.b.
rhodesiense was first recognized in south-east Uganda in
18981.  This epidemic which lasted until 1915, led to the
death of over 350,000 people in south-eastern Uganda
alone. Subsequently, there were a number of sporadic
outbreaks of the disease. However, in the 1940s, a second
major epidemic of sleeping sickness began in south-east
Uganda which led to 2432 cases and 274 deaths2. The
third major epidemic started in the 1970s and continued
up to the end of 1980s3. In 1988, sleeping sickness ex-
tended to Tororo and Busia districts at the Uganda-Kenya
border during which 1180 cases were reported. This epi-
demic was brought under control by the end of 1990s4.
Southeast Uganda still remains the major focus of T.b.
rhodesiense sleeping sickness with Glossina fuscipes
fuscipes as the major vector5.
Recent reports indicate that the area affected by T.b.
rhodesiense sleeping sickness has increased 2.5-fold since
19854, extending further north into Soroti, Kaberamaido,
Apac, Lira districts6 and probably Gulu district. This north-
ern spread of the disease could easily lead to the merger of
the south-eastern T.b. rhodesiense sleeping sickness fo-
cus with the north-western T.b. gambiense focus. This is
likely to complicate the epidemiology and control of the
two forms of the disease.  According to Simarro et al7,
T.b. rhodesiense cases reported in Uganda from 2000 to
2009 were: 300 (2000), 426 (2001), 329 (2002), 338
(2003), 335 (2004), 473 (2005), 261 (2006), 119 (2007),
138 (2008) and 129 (2009)7. Most of these cases were
reported in Iganga, Soroti, Kaberamaido, Dokolo and
Lira7. Most cases of T.b. rhodesiense are linked to live-
stock reservoirs7. Livestock reservoirs are important es-
pecially in south-east Uganda where these are responsible
for over 50% of the reported cases of T.b. rhodesiense
cases during the period 2000 to 20097.
Control of sleeping sickness mainly relies on case find-
ing and treatment8 coupled with tsetse control during epi-
demics to suppress transmission. Case finding is normally
focused on screening people in and around known foci of
the disease. Though not widely practised, there is growing
evidence that domestic animal reservoirs, including cattle,
pigs and small ruminants need to be treated to prevent
persistence and spread of T.b. rhodesiense sleeping sick-
ness9–11. The zoonotic nature of T.b. rhodesiense is well
recognized, and cattle and pigs have long been reported to
be its major reservoirs in south-east Uganda10, 12–15. Ani-
mal reservoirs have been incriminated in the persistence
of T.b. rhodesiense sleeping sickness in old foci10. Move-
ment of cattle from sleeping sickness endemic areas dur-
ing restocking programs is responsible for emergence of
new foci9. It is reported that up to 18% of the domestic
animals in emerging sleeping sickness foci may be acting
as reservoirs for the disease5.
Whereas the role of animal reservoirs is well-docu-
mented in the epidemiology of T.b. rhodesiense sleeping
sickness, targeting of animal reservoirs is rarely exploited
in the control of sleeping sickness. Moreover, case studies
on this control intervention in Rhodesiense sleeping sick-
ness foci in Africa and their follow-up reports are scarce.
Hence, we present a case study and its follow-up report
on three sleeping sickness foci in south-east Uganda where
mass-treatment and insecticide-spraying of cattle and pigs
were applied to suppress outbreaks of T.b. rhodesiense
sleeping sickness and monitored over a period of up to 17
years.
Buteba, Kisoko and Osukuru sleeping sickness foci
are located in Tororo district in south-east Uganda, an
area predominantly infested with G. fuscipes fuscipes.
Sleeping sickness outbreaks are normally focalized; af-
fecting a cluster of tsetse-infested villages16. Communi-
ties in these villages practise mixed crop-livestock farm-
ing, keeping mainly cattle and pigs which act as reservoirs
for T.b. rhodesiense.
Outbreaks of Human African Trypanosomiasis due
to T.b. rhodesiense occurred in Buteba (1990–91), Kisoko
(1992–93) and Osukuru (2001–02) foci in Tororo dis-
trict. Outbreaks were monitored through the number and
places of origin of patients admitted at the LIRI Hospi- J Vector Borne Dis 48, June 2011 106
tal—a sleeping sickness treatment centre in Tororo dis-
trict. In turn, an advance medical team went ahead to cre-
ate awareness among affected communities. The disease
signs and symptoms, mode of transmission, and impor-
tance of cattle and pigs as reservoirs for T.b. rhodesiense
were highlighted. At the end of each community educa-
tion session people in the affected villages were asked to
bring their cattle and pigs to designated areas for mass-
treatment and insecticide-spraying by the veterinary team
on programmed dates. The cluster of villages at different
places that constituted the sleeping sickness foci were tar-
geted during implementation of control interventions.
Control interventions were conducted in Kayoro Par-
ish, Buteba Subcounty in March 1991, Petta Parish,
Kisoko Subcounty in March 1993, and in Osukuru,
Nyalakot and Kayoro Parishes, Osukuru Subcounty in
April 2001. During the implementation of the control in-
terventions, all cattle and pigs presented were treated with
diminazene aceturate (Berenil®, Hoechst GmBH, Ger-
many) at a dosage rate of 7 mg/kg body weight. In addi-
tion, animal reservoirs were sprayed with deltamethrin
pour-on (Spoton®, Coopers, Harare, Zimbabwe) on the
backline at a dosage rate of 1ml/10 kg body weight. For
each village, the number of animals treated was recorded.
Following control interventions, sleeping sickness
patients reporting to LIRI Hospital from Buteba, Kisoko
and Osukuru foci were monitored through patient records
from the time of the outbreaks in 1991 to 2008.  As shown
in Fig. 1,  from January 1990 to March 1991, 59 patients
presented for treatment from Buteba focus. During the
proceeding outbreaks, 18 patients presented from Kisoko
focus from May 1992 to February 1993 (Fig. 2) and 69
patients presented from Osukuru focus from January 2001
to January 2002 (Fig. 3).
The number of tsetse hosts and animal reservoirs
(cattle and pigs) treated and sprayed during the outbreaks
in Buteba, Kisoko and Osukuru foci are shown in Table
1. By January 2008, 6–17 years since the last outbreaks,
no resurgence of sleeping sickness outbreak was observed
in these foci.    
Although cattle and pigs are the most important do-
mestic animal reservoirs in south-east Uganda10, 13, 15, 17, 18,
earlier interventions mainly targeted cattle as was the case
in Buteba focus. This was mainly because cattle were the
dominant livestock type in the area. Blood meal studies
Fig. 1: Distribution of T.b. rhodesiense sleeping sickness patients
from Buteba focus in Tororo district, Uganda during the out-
break from 1990 to 1991.
Fig. 2: Distribution of T.b. rhodesiense sleeping sickness patients
from Kisoko focus in Tororo district, Uganda during the out-
break from 1992 to 1993.
Fig. 3: Distribution of T.b. rhodesiense sleeping sickness patients
from Osukuru focus in Tororo district, Uganda during the
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have shown that the number of times tsetse feeds on cattle
is proportional to the number of cattle in the domestic
herds15. During intervening years, however, as more evi-
dence unfolded, interventions targeted both cattle and pigs
as was the case in Kisoko and Osukuru foci. Blood meal
analysis has consistently shown that cattle, pigs and moni-
tor lizards are the most preferred hosts for G. fuscipes
fuscipes in south-east Uganda15. Inclusion of pigs in mass
treatment and insecticide spraying is of epidemiological
significance given that communities in disease foci keep
pigs within homesteads where G. fuscipes fuscipes is re-
ported to be predomestic19. Current thinking is that a whole
range of domestic reservoirs, including cattle, pigs, sheeps
and goats needs to be treated. Previous omission of pigs,
sheeps and goats during treatment is reported to be partly
responsible for the continued persistence of sleeping sick-
ness in south-east Uganda20. Upon realization of the im-
portance of livestock reservoirs in propagation of cases of
T.b. rhodesiense sleeping sickness in Uganda, Waiswa
and Kabasa21, embarked on a programme to treat 200,000
cattle with diminazene aceturate and spray them with
deltametrin in the Districts of Soroti, Kaberamaido,
Dokolo, Lira, Amolatar and Apac. This programme is
reported to have decreased the prevalence of T. brucei s.l.
in cattle by 70% within one year of implementation21.
Combination of chemotherapy and application of in-
secticide pour-on on cattle is proven to exert rapid sup-
pression of trypanosomiasis and tsetse population22, 23.
However, mass-treatment of livestock with isometamidium
chloride coupled with limited vector control in some foci
in Soroti of Uganda did not yield the desirable impact on
the prevalence of T.b. rhodesiense in cattle6. Because to
be effective in the prevention of parasite transmission from
livestock to people, mass-treatment and insecticide-spray-
ing have to cover enough livestock (over 95%). In the
present case study, the treatment and spraying campaign
targeted over 95% of the cattle and pigs in the entire clus-
ter of villages within the sleeping sickness focus. For lo-
gistic reasons, an approach involving gathering of cattle
in designated communal areas coupled with “house-to-
house visits” in search for pigs yielded excellent animal
reservoir coverage. Combination of mass-treatment and
vector control is likely to minimize occurrence and spread
of drug resistant parasites. Economic evidence suggests
that financial benefits of treating the animal reservoirs for
T.b. rhodesiense sleeping sickness would be more than
cover the costs of treatment24. Treatment of animal reser-
voirs is beneficial to animal health and productivity. Low-
ering the incidence of sleeping sickness by treating animal
reservoirs reduces the cost of treating human patients24.
In addition, it reduces the incidence of drug failure and
toxicity associated with most especially melarsoprol—a
drug for treatment of late stage cases25,26.
 In principle, livestocks for sale in sleeping sickness
endemic areas in south-east Uganda are required to be
treated before sale as a matter of Government policy27,
however, the policy has proved difficult to implement at a
local level due to decentralization of public services6. Dif-
ferent aspects of control, i.e. tsetse, human and animal
trypanosomiasis being handled by different government
departments in most sleeping sickness endemic countries
is another bottleneck. Successful implementation of mass-
treatment and insecticide-spraying of animal reservoirs
demands for inter-sectoral cooperation among veterinary,
agriculture and health services at all levels 25,26.
 In conclusion, application of mass-treatment and in-
secticide-spraying of animal reservoirs in disease foci as
an emergency control intervention for T.b. rhodesiense
sleeping sickness outbreaks by governments is recom-
mended. There is need for further studies on the integra-
tion of land-use practices that eliminate tsetse habitats with
application of mass-treatment and spraying of animal res-
ervoirs in rhodesiense sleeping sickness foci.
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